Showing posts with the label Bharat Biotech submits vaccine data for phase 2/3 trials on children between 2-18 years to DCGI
Bharat Biotech submits vaccine data for phase 2/3 trials on children between 2-18 years to DCGI

Bharat Biotech submits vaccine data for phase 2/3 trials on children between 2-18 years to DCGI

admin

The paediatric Covaxin is similar to the one administered to adults – two doses…

Load More That is All